Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00754273 · ClinicalTrials.gov registry record

An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS

A clinical trial of Methicillin-resistant Staphylococcal Aureus Pneumonia, sponsored by University of Kentucky.

Completed
Registry status
1,250
Enrollment target
1
Study location

NCT00754273 is a study of Methicillin-resistant Staphylococcal Aureus Pneumonia that has completed, run by University of Kentucky. The registered enrollment target is 1,250 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00754273, a study of Methicillin-resistant Staphylococcal Aureus Pneumonia, has completed, sponsored by University of Kentucky.

COMPLETED
Registry status
1,250 participants
Enrollment target
1
Study location

Study Summary

To determine the prevalence of MRSA isolates with marginal susceptibility to vancomycin or heteroresistance.

Interventions

  • OTHER etest susceptability testing

Study Locations (1)

Kentucky

  • University of Kentucky Medical Center - Lexington

Trial Details

FieldValue
Enrollment Target 1,250 participants
Start Date 2008-09
Est. Completion 2010-07

Sponsor

University of Kentucky

54 total trials

What the Registry Record Tells You About NCT00754273

The ClinicalTrials.gov registry entry for NCT00754273 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Methicillin-resistant Staphylococcal Aureus Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which etest susceptability testing is the first listed.

NCT00754273 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT00754273 about?

NCT00754273 is a clinical study titled "An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS". To determine the prevalence of MRSA isolates with marginal susceptibility to vancomycin or heteroresistance.

What is the current status of trial NCT00754273?

This trial is currently completed. The enrollment target is 1,250 participants. The study started on 2008-09. Estimated completion is 2010-07.

What conditions does trial NCT00754273 study?

This clinical trial studies the following conditions: Methicillin-resistant Staphylococcal Aureus Pneumonia.

What interventions are being tested in trial NCT00754273?

The interventions under investigation include: etest susceptability testing (OTHER).

Who is sponsoring clinical trial NCT00754273?

This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00754273 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.